Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Ambrisentan by Noorik Biopharmaceuticals for Hepatorenal Syndrome: Likelihood of Approval
Ambrisentan is under clinical development by Noorik Biopharmaceuticals and currently in Phase II for Hepatorenal Syndrome. According to GlobalData, Phase...